|
Ignatius W. Fong Professor of Medicine at the University of Toronto. He was Chief of Infectious Diseases at St. Michael's Hospital for 29 years until 2005. He has published >160 articles in medical journals and authored or edited 5 medical books. Dr. Fong has also been a peer reviewer for over a dozen medical journals. He received his medical degree from the University of West Indies, post graduate medical resident training at the University of Toronto and University of Ottawa, and his fellowship in Infectious Diseases at the University of Washington (Seattle). Research interests include the study of AIDS-related complications (e.g. PML), clinical trials with new HIV anti-retrovirals and understanding the neuroendocrine response in HIV. He is also interested in understanding the relationship between Chlamydia pneumoniae and atherosclerosis for which he has developed a rabbit model.
(Flyer for Dr. Wong's new textbook) ProductFlyer_978-0-387-72417-1[1].pdf |
St. Michael's Hospital
30 Bond Street
Cardinal Carter Wing 4-179
Toronto, ON
M5B 1W8
CA
Phone Number(s)
(416) 864-5746
Fax Number(s)
(416) 864-5310
E-mail Address(es)
fongi@smh.ca  |
Recent papers include: Chlamydial heat-shock protein-60 antibody and correlation with chlamydia pneumoniae in atherosclerotic plaques. J Infect Dis 2002;186(10):1469-73; Influence of clarithromycin on early atherosclerotic lesions after chlamydia pneumoniae infection in a rabbit model. Antimicrob Agents Chemother 2002;46(8):2321-6. |
|
Kevin Gough , MD, FRCPC: Division Director of Infectious Diseases. Infectious Disease Consultant. Research interests include post-exposure prophylaxis and clinical studies on antiretroviral medications / toxicities and opportunistic infections.
|
kevin.gough@utoronto.ca
St. Michael's Hospital
30 Bond Street
Cardinal Carter Wing 4-180
Toronto, Ontario, M5B 1W8
416-864-5568 |
Recent papers include: Yudin MH, Steele DM, Sgro MD, Read SE, Kopplin P, Gough KA. Severe acute respiratory syndrome in pregnancy. Obstet Gynecol. 2005 Jan;105(1):124-7; Antoniou T, Yoong D, Beique L, Chihrin S, Rachlis A, Gough K, Loutfy M. Impact of Acid-Suppressive Therapy on Virologic Response to Atazanavir-Based Regimens in Antiretroviral-Experienced Patients: A Case Series. J Acquir Immune Defic Syndr. 2005 May 1;39(1):126-128. (Letter to the Editor); Walmsley, SL, J. Raboud, JB. Angel, T. Mazzulli, S. Shen, L. Casciaro, CD. Young, G. Moussa, K. Gough, A. Rachlis, and J. Hopkins. Long-term Follow-up of a Cohort of HIV-infected Patients Who Discontinued Maintenance Therapy for Cytomegalovirus Retinitis. HIV Clinical Trials;7(1):1-9, 2006
|
|
Kamran Khan MD (University of Toronto '96), MPH (Columbia University, NY '02), FRCPC (Internal Medicine '99, Infectious Diseases '02, Preventive Medicine '03 - ABPM). Dr. Khan completed his undergraduate medical training at the University of Toronto. He subsequently completed training in Internal Medicine at the University of Minnesota pursuing a career track in Immigrant and Refugee Health. Subsequently he completed fellowships in Infectious Diseases and also in Preventive (Community) Medicine both at Cornell in addition to a two-year research fellowship at the Harvard School of Public Health.
Currently, Dr. Khan is a clinician-scientist at St. Michael's Hospital with an interest in population mobility and emerging infectious diseases. He conducts his research from the Centre for Research on Inner City Health on issues related to immigration, tuberculosis, and other infectious diseases prevalent in immigrant and refugee populations. He is currently also working in collaboration with the airline industry to study the global airline transportation network as a way to better understand how pandemics of the 21st century might fold. From a methodological perspective, Dr. Khan studies involve clinical and population epidemiology, large dataset analysis, economic evaluation, and mathematical modeling.
|
St. Michael's Hospital
30 Bond Street
Toronto, ON
M5B 1W8
CA
Phone Number(s)
(416) 864-6060
Fax Number(s)
(416) 864-5485
E-mail Address(es)
km.khan@utoronto.ca |
Recent papers/works include: Khan K, Wang J, Hu W, Bierman A, Li Y, Gardam M. Tuberculosis Infection in the United States: National Trends over Three Decades. American Journal of Respiratory and Critical Care Medicine. (in press); Menzies D, Khan K. Diagnosis of Tuberculosis Infection and Disease.
Canadian Tuberculosis Standards, 6th Edition, 2007; Khan K, Wang J, Marras T. Sensitization to Non-Tuberculous Mycobacteria in the United States: Emerging National Trends Over Three Decades. American Journal of Respiratory and Critical Care Medicine; 176(3):306-313, Aug 1st, 2007; Cook L, Khan K, Richardson R, Wang J, Dedier H, Gardam M. Establishing a Diagnostic Standard for Latent Tuberculosis Infection in an Anergic Population: The TSPOT TB test versus the Tuberculin Skin Test versus an Expert Physician Panel. Clinical Journal of the American Society of Nephrology; 2: 68–73, Jan 2007; Khan K, Campbell A, Wallington T, Gardam M. The Impact of Physician Training and Experience on Tuberculosis Patient Survival in Toronto, Canada. Canadian Medical Association Journal (CMAJ); 175(7):749-53, Sept 2006; Khan K, Muennig P, Behta M, Zivin JG. Global drug resistance patterns and the management of latent tuberculosis infection in immigrants to the United States. New England Journal of Medicine; 347(23):1850-9, 2002 Dec 5. |
|
Mario Ostrowski MD, FRCPC: Associate Professor in Medicine/Immunology/Pathology, Infectious Diseases Consultant at SMH.
Research interests include HIV and HCV immunopathogenesis, and vaccine development. |
St. Michael's Hospital
30 Bond St.
Toronto, Ontario, M5B 1W8
Phone (416) 946-5805 Ext Fax (416) 978-
8765
E-mail: mario.ostrowski@gmail.com |
Selected publication:
Stanley SK, Ostrowski MA, Justement JS, Gantt K, Hedayati S, Mannix M, Roche K,. Schwartzentruber DJ, Fox C, and Fauci AS: Effect of immunization with a common recall antigen on plasma viremia and in vitro virus isolation in HIV-1 infected individuals. N Engl J Med 334:1222-1230, 1996.
Ostrowski M , Krakauer D, Li Y, Justement S, Learn G, Ehler L, Stanley S, Nowak, Fauci A. The effect of immune activation on the dynamics of HIV replication and on the distribution of viral quasispecies. Journal of Virology, 72; 7772-7784, 1998.
M A. Ostrowski , Qigui Yu, Feng Yun Yue,Jun Liu, Brad Jones, Xiao X. Gu, Mona Loutfy, Colin M Kovacs, Roberta Halpenny. Why can't the immune system control HIV-1? Defining HIV-1 specific CD4+ T cell immunity in order to develop strategies to enhance viral immunity. Immunol Res;35(1-2):89-102. Review, 2006.
Ostrowski, M.A, Justement S., Ehler L, Mizell S, Lui S, Mican J, Walker B, Thomas E, Seder R and Fauci A. The Role of CD4+ T cell Help and CD40 Ligand in the Expansion of HIV-Specific Memory Cytotoxic CD8+ T Cell Responses. Journal of Immunology: 165:6133-6141, 2000.
Chun, T.W., Davey, R.T., Ostrowski, M.A., Engel, D., Mullins, J.I., Lane, H.C., and Fauci, A.S. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia following discontinuation of highly active antiretroviral therapy. Nature Medicine Jul;6(7): 757-61, 2000.
Ostrowski, M.A., Chun, T.W., and Fauci A.S. Revision of: Detection Assays for HIV Proteins, Unit 12.5. Current Protocols in Immunology, update, 2005.
Q. Yu, J.X. Gu, H. Schwartz, C. Kovacs, M.A Ostrowski. OX40-Ligation of CD4+ T cells Enhances Virus Specific CD8+ T cell Memory Responses Independently of IL-2 and CD4+ T Regulatory Cell Inhibition. Journal of Immunology, 176: 2486-2495, 2006.
Martin D. Hyrcza, Colin Kovacs, Mona Loutfy, Roberta Halpenny, Lawrence Heisler, Stuart Yang, Olivia Wilkins, Mario Ostrowski (co-senior author),Sandy D. Der. Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in HIV infection and are characterized by chronic interferon response as well as extensive transcriptional changes in CD8+ T-cells. J Virol. 2007 Jan 24 (epud ahead of print).
Xiao Xiao Gu, Feng Yun Yue, Colin Kovacs, and Mario Ostrowski. The Role of Cytokines which Signal through the Common gamam Chain Cytokine Receptor in the Reversal of HIV Specific CD4+ and CD8+ T Cell Anergy. PLOSone 2007 Mar 21;2:e300.
Keith E. Garrison, R. Brad Jones, Duncan A. Meiklejohn, Naveed Anwar, Lishomwa C. Ndhlovu, Joan M. Chapman, Ann L. Erickson, Ashish Agrawal, Gerald Spotts, Fredrick M. Hecht, Seth Rakoff-Nahoum, Jack Lenz, Mario A. Ostrowski, Douglas F. Nixon PLOS Pathogens 2007 Nov 9;3(11):e165. |
|
Matthew Muller MD (University of Toronto ’97), PhD, FRCPC (Intern Med, Infect Dis): Infectious Diseases Consultant, Hospital Epidemiologist, Associate Medical Director of Infection Prevention and Control at St. Michael's Hospital.
My research interests are in issues relating to infection prevention and control and include emerging infections including SARS, the epidemiology and control of MRSA, C. difficile and ESBL mediated resistance among common gram negative organisms, as well as the behavioral and practical aspects of hand hygiene promotion. Ongoing projects include a decision analysis examining the role of antibiotic prophylaxis in hernia surgery with an emphasis on the impact of C.difficile, an analysis of 3 years of data on ESBL acquisition, transmission and clearance among residents of long term care facilities in Durham, York, and Toronto. Newer projects are centering on novel approaches to improve hand hygiene compliance, studies of MRSA decolonization and the epidemiology of community-acquired MRSA and a systematic review of infection control strategies for gram negative organisms, particularly ESBLs. |
Mount Sinai Hospital
Suite 1460
600 University Avenue
Toronto, ON
M5G 1X5
CA
Phone Number(s)
(416) 586-5200
Fax Number(s)
(416) 586-3140
E-mail Address(es)
mullerm@smh.ca |
Recent papers include: MP Muller, L Dresser, J Raboud, A McGeer, E Rea, SE Richardson, T Mazzulli, M Loeb, M Louie. Adverse events associated with high dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome. Pharmacotherapy 2007:27(4):494-503.
Recent papers include: Adverse events associated with high dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome. Pharmacotherapy 2007:27(4):494-503; Alternative Methods of Estimating an Incubation Distribution. Epidemiology 2007: 18(2):253; Development of a triage protocol for critical care during an influenza pandemic. CMAJ, 2006: 175(11):1377-1381; Clinical prognostic rule for severe acute respiratory syndrome in low- and high- resource settings. Arch Intern Med 2006: 166;1-8; Early Diagnosis of SARS: lessons from the Toronto SARS outbreak. Euro J Clin Microbiol Infect Dis, 2006:25;230-237; Can Routine Laboratory Tests Discriminate Between SARS and Other Causes of Community-Acquired Pneumonia? Clin Infect Dis 2005;40:1079-1086; Clinical Trials and Novel Pathogens: Lessons Learned from SARS. EID; 2004;10(3):389-394
|
|
